Jubilant Biosys Opens Integrated Discovery and Scale-Up Facility to Meet Rising Global Biopharma Demand

 Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India ...

January 14, 2026 | Wednesday | News
Hongene Biotech Secures Gates Foundation Grant to Advance Equitable mRNA Vaccine Manufacturing

Hongene Biotech announced the receipt of a grant from the Gates Foundation to develop high-quality, affordable, and patent-free cap analogs for use ...

January 14, 2026 | Wednesday | News
ChemWerth Appoints Chandrakanth Reddy as General Sales Manager in India

-ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengt...

January 13, 2026 | Tuesday | News
Aragen Launches CHOMax™ Platform to Accelerate Monoclonal Antibody Development from DNA to IND

Accelerated pathway: Integrated cell line development, process development, analytics, GMP drug substance, plus drug product support through quali...

January 12, 2026 | Monday | News
Shilpa Medicare’s OERIS™ Clears Phase 3, Showing Superior Convenience, Efficacy and Safety in CINV

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondans...

January 12, 2026 | Monday | News
Eisai and Biogen Secure NMPA Acceptance for Subcutaneous LEQEMBI in China

If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for...

January 07, 2026 | Wednesday | News
MindRank Initiates Pivotal Phase III Trial for AI-Designed Oral GLP-1 Candidate MDR-001

MDR-001 progressed from program discovery to Phase III in just 4.5 years, much faster than traditional development cycles. Phase IIb data demonstrated...

January 07, 2026 | Wednesday | News
WuXi Biologics Achieves ISO 20400 Sustainable Procurement Certification, Strengthening Global Supply Chain Resilience

WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrate...

January 06, 2026 | Tuesday | News
Kelun-Biotech’s TROP2 ADC sac-TMT Combo with Keytruda Granted Breakthrough Therapy Designation in China for First-Line NSCLC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK)  announced that its TROP2-directed antibody-drug ...

January 06, 2026 | Tuesday | News
Samsung Bioepis Reclaims European Commercial Rights for BYOOVIZ®, Expanding Direct Biosimilar Portfolio

Samsung Bioepis completes full transfer of commercial rights from Biogen back to Samsung Bioepis for BYOOVIZ® BYOOVIZ becomes the fourth biosimi...

January 05, 2026 | Monday | News
Mabwell Secures Indonesian Approval for Adalimumab Biosimilar JUNMAIKANG

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its Adalimumab Injection 9MW01...

January 02, 2026 | Friday | News
Valneva Regains Full Rights to Single-Shot Chikungunya Vaccine, Ends Licensing Deal with Serum Institute of India

Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), a Cyrus Poonawalla Grou...

January 02, 2026 | Friday | News
Mabwell Doses First Patient in World’s First Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of...

January 01, 2026 | Thursday | News
Transcenta Therapeutics Enters Strategic Bioprocessing Collaboration With EirGenix

  Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-inte...

December 31, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close